Testing utidelone with capecitabine for HER2-negative breast cancer that has spread to the brain
Official title: A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This trial is testing two cancer drugs in people whose breast cancer has spread to the brain.
Read our full plain-language summary
What the trial team says
This study is a multicenter, two-stage clinical trial to evaluate the efficacy and safety of utidelone in combination with capecitabine in patients with HER2-negative breast cancer with brain metastases. Patients will be enrolled to receive treatment of utidelone alone or in combination with capecitabine. The objectives both in stage I and stage II are to evaluate the intracranial and systemic efficacy and safety of utdelone plus capecitabine for the treatment of HER2-negative breast cancer patients with brain metastases.
Key facts
- Registry number
- NCT06764940
- Stage of testing
- Phase 2
- Conditions studied
- HER2-negative Breast Cancer Patients With Brain Metastases
Where it is running
This trial lists 12 sites.
-
California
- City of Hope--Duarte (Duarte)
- Univ. of California Los Angeles (Los Angeles)
- Scripps Health (San Diego)
-
Colorado
- University Of Colorado Hospital - Anschutz Cancer Pavilion (Aurora)
-
Georgia
- Augusta University (Augusta)
-
Illinois
- Robert H. Lurie Comprehensive Cancer Center Northwestern University (Chicago)
-
Maryland
- The Johns Hopkins Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine (Baltimore)
-
Nevada
- Comprehensive Cancer Centers of Nevada (Las Vegas)
-
New York
- Stony Brook Cancer Center (Stony Brook)
-
Texas
- MD Anderson Cancer Center (Houston)
- Community Clinical Trials (Kingwood)
- Tranquil Clinical Research (Webster)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.